The issue of progressive cognitive decline in patients with schizophre
nia has been debated. We performed a cross-sectional study of patients
with chronic schizophrenia, aged from 18 to 69 years, in order to add
ress this issue. The patients included in this study passed a rigorous
screen for any comorbid condition with an adverse impact on central n
ervous system function. We assessed intellectual deterioration with a
battery of neuropsychological tests known to be sensitive to cognitive
impairment in progressive dementia. No evidence of accelerated intell
ectual decline was found. No significant differences were found betwee
n the five age-derived cohorts (18-29, 30-39, 40-49, 50-59, and 60-69
years of age) on the Mini-Mental State Examination, Dementia Rating Sc
ale, or other tests sensitive to dementia. While performance on the Bo
ston Naming Test significantly declined with age, this was mainly due
to age rather than duration of illness. However, it is important to no
te that mean performances on the majority of the tests were abnormal a
cross all cohorts studied. These results suggest that intellectual fun
ction does not markedly decline during the adulthood of patients with
schizophrenia. The course of schizophrenia is more consistent with a s
tatic encephalopathy than a dementing disorder.